Valuation
Pharmaceutical PreparationsLive · Yahoo FinancePrice
$22.33
52-Week Range
Decision Context
Scores are balanced across the six engines. No single dimension dominates — this is consistent with a stable, mid-tier quality business.
Based on filing period ending Mar 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
SWOT Analysis — INVA
Inflationary BoomStrengths
Net Income: $271.2M (+1059.2% YoY) — Profit grew 1059% — the company kept more of each dollar earned.
EPS (Diluted): $3.30 (+816.7% YoY) — Earnings per share rose 817% — each share earned more.
Revenue: $217.2M (+62.6% YoY) — Revenue grew 63% — the company sold more goods or services than the prior year.
Total Assets: $1.6B (+25.7% YoY) — Total assets grew 26% — the company's resource base expanded.
Weaknesses
No material weaknesses flagged.
Opportunities
Operating Cash Flow: $196.9M (+4.4% YoY) — Operating cash flow grew 4% — the business generated more cash from day-to-day operations.
Threats
Gross margin compressed by 80.1pp — input costs or pricing pressure is eroding profitability on each dollar of revenue.
Financial Charts
Revenue vs Net Income
Gross Profit vs Operating Income
Margin Trend
Operating Cash Flow
Year-over-Year Changes
Net Income
$271.2M
was $23.4M
Profit grew 1059% — the company kept more of each dollar earned.
EPS (Diluted)
$3.30
was $0.36
Earnings per share rose 817% — each share earned more.
Revenue
$217.2M
was $133.6M
Revenue grew 63% — the company sold more goods or services than the prior year.
Total Assets
$1.6B
was $1.3B
Total assets grew 26% — the company's resource base expanded.
Operating Cash Flow
$196.9M
was $188.7M
Operating cash flow grew 4% — the business generated more cash from day-to-day operations.
Risk Flags
0 high · 1 medium · 0 low- ◈ Medium
Gross margin compressed by 80.1pp — input costs or pricing pressure is eroding profitability on each dollar of revenue.
Price History
Technical Signals
Daily closes · 1-year dataLatest News
via FinnhubGet the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade INVA
Links open broker research pages. Not an endorsement or recommendation.
Research INNOVIVA, INC.
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.